Evidence map›Paper›PMID 20042519›Full record

ArticleClinical and vaccine immunology : CVI2010

Specific IgG responses to recombinant antigen B and em18 in cystic and alveolar echinococcosis in china.

Tiaoying Li, Akira Ito, Xingwang Chen, Yasuhito Sako, Jiamin Qiu, Ning Xiao, Dongchuan Qiu, Minoru Nakao, Tetsuya Yanagida, Philip S Craig

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Echinococcosis: Advances in the 21st Century.Clinical microbiology reviews · 2019
    Review
  5. Article
  6. Article
  7. Ultrasound and Cystic Echinococcosis.Ultrasound international open · 2018
    Review
  8. Article
  9. Factors Influencing the Serological Response in Hepatic Echinococcus granulosus Infection.The American journal of tropical medicine and hygiene · 2016
    Article
  10. Article
  11. Evaluation of immunochromatographic test for the detection of antibodies against Echinococcosis granulosus.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Tiaoying LiInstitute of Parasitic Diseases, Sichuan Centers for Disease Control and Prevention, Chengdu 610041, Sichuan Province, China. litiaoying@sina.com
Akira Ito
Xingwang Chen
Yasuhito Sako
Jiamin Qiu
Ning Xiao
Dongchuan Qiu
Minoru Nakao
Tetsuya Yanagida
Philip S Craig
University of Salford · GBSichuan Center for Disease Control and Prevention · CNAsahikawa Medical College Hospital · JP

Funding

PARASITIC ZOONOSIS (ECHINOCOCCOSIS) TRANSMISSION IN CHINR01TW001565 · FIC · UNIVERSITY OF SALFORD · PI CRAIG, PHILIP SIMON · 2000 to 2007
$3.5M
FIC NIH HHS R01 TW001565
6 · The paper itself

Abstract

An understanding of the correlation of the specific antibody responses and the disease phase is essential in evaluating diagnostic values of immunological tests in human echinococcosis. In this study, 422 echinococcosis patients diagnosed by ultrasonography, including 246 with cystic echinococcosis (CE), 173 with alveolar echinococcosis (AE), and 3 with dual infection, were tested for specific IgG in sera against recombinant AgB (rAgB) and recombinant Em18 (rEm18) in an enzyme-linked immunosorbent assay. As a result, rAgB-specific antibody was detected in 77.6% of CE and 86.1% of AE patients, while rEm18-specific antibody was present in 28.9% of CE and 87.3% of AE patients. Additionally, all three patients with dual infection exhibited specific antibodies responding to rAgB and rEm18. Further analysis revealed that rAgB-specific antibody was elevated in a significantly greater proportion (87.3%) of CE patients with cysts at active or transitional stages (CE1, CE2, or CE3), compared to 54.8% of other patients with cysts at an early or an inactive stage (CL or CE4 or CE5). Furthermore, rAgB-specific antibody was detected in 95.6% of CE2 cases, which was statistically greater than that (73.7%) in CE1 patients. Although rEm18-specific antibody was elevated in 28.9% of CE patients, the positive reaction was much weaker in CE than in AE cases. Serum levels and concentrations of rEm18-specific antibody were further indicated to be strongly disease phase correlated in AE patients, with positive rates of 97.4% in cases with alveolar lesions containing central necrosis and 66.7% in patients with early alveolar lesions that measured </=5 cm.

Indexed as

Antibodies, HelminthAntigens, HelminthChinaEchinococcosisEnzyme-Linked Immunosorbent AssayHelminth ProteinsHumansImmunoglobulin GLipoproteinsRecombinant ProteinsAntibodies, Helminthantigen B, EchinococcusAntigens, HelminthEm18 antigenHelminth ProteinsImmunoglobulin GLipoproteinsRecombinant Proteins

Identifiers

PMID20042519
PMCPMC2837958
OpenAlexW2099173458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.